Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Mar;37(2):255-6.
doi: 10.1093/schbul/sbq162. Epub 2011 Jan 18.

Food and Drug Administration commentary on methodological issues in negative symptom trials

Thomas Laughren  1 , Robert Levin
Affiliations
Comment

Food and Drug Administration commentary on methodological issues in negative symptom trials

Thomas Laughren et al. Schizophr Bull. 2011 Mar.
No abstract available

PubMed Disclaimer

Comment on

  • Methodological issues in negative symptom trials.
    Marder SR, Daniel DG, Alphs L, Awad AG, Keefe RS. Marder SR, et al. Schizophr Bull. 2011 Mar;37(2):250-4. doi: 10.1093/schbul/sbq161. Epub 2011 Jan 26. Schizophr Bull. 2011. PMID: 21270473 Free PMC article.

References

    1. Laughren T, Levin R. Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim. Schizophr Bull. 2005;32:220–222. - PMC - PubMed
    1. Buchanan RW, David M, Goff G, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005;31:1–15. - PubMed
    1. Harvey PD, Koren D, Reichenberg A, et al. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006;32:250–258. - PMC - PubMed

MeSH terms

Substances